Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy.
about
A placebo-controlled, randomized trial of mesenchymal stem cells in COPD.Rationale and design of the allogeneiC human mesenchymal stem cells (hMSC) in patients with aging fRAilTy via intravenoUS delivery (CRATUS) study: A phase I/II, randomized, blinded and placebo controlled trial to evaluate the safety and potential efMesenchymal Stem Cells Reversed Morphine Tolerance and Opioid-induced Hyperalgesia.Mesenchymal stem cells improved the ultrastructural morphology of cerebral tissues after subarachnoid hemorrhage in rats.Cartilage restoration in haemophilia: advanced therapies.Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles.Development of a surrogate potency assay to determine the angiogenic activity of Stempeucel®, a pooled, ex-vivo expanded, allogeneic human bone marrow mesenchymal stromal cell productMolecular and Cellular Interactions of Allogenic and Autologus Mesenchymal Stem Cells with Innate and Acquired Immunity and Their Role in Regenerative Medicine.Isolation, expansion and characterisation of mesenchymal stem cells from human bone marrow, adipose tissue, umbilical cord blood and matrix: a comparative study.Blastema cells derived from New Zealand white rabbit's pinna carry stemness properties as shown by differentiation into insulin producing, neural, and osteogenic lineages representing three embryonic germ layers.Antifibrotic Activity of Human Placental Amnion Membrane-Derived CD34+ Mesenchymal Stem/Progenitor Cell Transplantation in Mice With Thioacetamide-Induced Liver Injury.Designing clinical-grade integrated strategies for the downstream processing of human mesenchymal stem cells.Autologous Mesenchymal Stem Cell and Islet Cotransplantation: Safety and Efficacy.Comparison between isolation protocols highlights intrinsic variability of human umbilical cord mesenchymal cells.
P2860
Q36411255-363793F7-3D32-49E3-959A-F3EB8718D803Q37022045-FF5AF84C-7242-437B-A829-6D548DAE22ADQ37198850-FD0AFA78-53CA-42DE-887C-C98625F2B117Q37700141-E11B8A98-FA0A-4517-8611-D044EEFFC27EQ38012177-D7F7CEBD-FC07-484F-AF5C-0CB6190C9F01Q38256369-A1FB2321-B8C4-4886-B82C-AAA0914D5E2BQ38936941-2F14CFE0-C9E3-42C6-AE33-E954EB514BA9Q39175513-84593D63-BCD5-4EC9-A68E-E3E5C1796092Q39198131-575FB93F-FB78-44D0-92D9-7AE8369267C9Q40674950-2721714F-7C5B-482D-8617-93ED06732864Q42708757-95E5C06F-A39D-4EC2-90F7-AA2D8E5D2246Q45860983-97C57362-CDF3-4A9F-B299-C22C1306AA51Q47155255-B221C97E-83D5-4392-858C-D858BC40A88DQ52932358-64D9FFF3-71A0-4692-B653-BEBF92A89865
P2860
Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Potential clinical application ...... tem cell (Prochymal®) therapy.
@en
Potential clinical applications of adult human mesenchymal stem cell
@nl
type
label
Potential clinical application ...... tem cell (Prochymal®) therapy.
@en
Potential clinical applications of adult human mesenchymal stem cell
@nl
prefLabel
Potential clinical application ...... tem cell (Prochymal®) therapy.
@en
Potential clinical applications of adult human mesenchymal stem cell
@nl
P2860
P356
P1476
Potential clinical application ...... tem cell (Prochymal®) therapy.
@en
P2093
Jorge Genovese
P2860
P356
10.2147/SCCAA.S11991
P50
P577
2011-11-17T00:00:00Z